RAPT Therapeutics, Inc.
RAPT · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $170 | $47 | $39 | $24 |
| Short-Term Investments | $61 | $111 | $210 | $166 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $4 | $3 | $4 | $3 |
| Total Curr. Assets | $235 | $162 | $253 | $193 |
| Property Plant & Equip (Net) | $5 | $8 | $9 | $3 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $4 | $4 | $3 |
| Total NC Assets | $5 | $12 | $14 | $6 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $240 | $173 | $266 | $199 |
| Liabilities | – | – | – | – |
| Payables | $1 | $5 | $3 | $2 |
| Short-Term Debt | $0 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $1 |
| Other Curr. Liab. | $7 | $8 | $5 | $3 |
| Total Curr. Liab. | $48 | $22 | $14 | $10 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $1 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $2 |
| Total NC Liab. | $2 | $4 | $7 | $3 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $4 | $7 | $9 | $0 |
| Total Liabilities | $50 | $26 | $21 | $12 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$615 | -$485 | -$368 | -$284 |
| AOCI | $0 | $0 | -$0 | -$0 |
| Other Equity | $0 | $0 | $0 | $0 |
| Total Equity | $190 | $147 | $245 | $186 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $240 | $173 | $266 | $199 |
| Net Debt | -$170 | -$47 | -$39 | -$24 |